Heroin

Parkway Clinical Laboratories Launches Xylazine Testing

Retrieved on: 
Monday, May 8, 2023
Xylazine, Therapeutic drug monitoring, Naloxone, Urine, CAP, Multimedia, Heroin, PCL, DEA, EIA, Pain management, Fentanyl, Saliva, Substance abuse, Pharmaceutical industry

PHILADELPHIA, May 8, 2023 /PRNewswire/ -- Parkway Clinical Laboratories Inc. (PCL), today announced it has launched Xylazine aka "Tranq" testing via LCMSMS confirmation testing on urine specimens.

Key Points: 
  • PHILADELPHIA, May 8, 2023 /PRNewswire/ -- Parkway Clinical Laboratories Inc. (PCL), today announced it has launched Xylazine aka "Tranq" testing via LCMSMS confirmation testing on urine specimens.
  • This test is well suited for the purpose of addiction screening and opioid prescription drug monitoring and can help identify past or recent usage of xylazine.
  • Xylazine may result in life threatening side effects that appear to be similar to those commonly associated with opioid use, making it difficult to distinguish opioid overdoses from xylazine exposure.
  • Parkway Clinical Laboratories (PCL) is a College of American Pathologists (CAP) accredited, CLIA-certified, full service, specialty reference laboratory.

NYU Langone to Study Ability of Overdose Prevention Centers to Counter Unprecedented Overdose Crisis

Retrieved on: 
Monday, May 8, 2023
Harm reduction, Newport State Airport (Rhode Island), Nuffield Department of Population Health, OPC, Doctor of Public Health, Inhalation, School of Public Health, Environment & Energy Publishing, Social support, Public, NYU, Security, Fentanyl, Research, Census of agriculture, Heroin, Bangladesh Technical Education Board, Doctor of Philosophy, NYU Langone Health, Public health, Brown University School of Public Health, National Institute on Drug Abuse, Drug, Population health, School, Brown University, NIDA, Epidemiology, NIH, Pharmaceutical industry, Tourism, Medical device, Risk management, Health, MD, Policy

No funds from the National Institutes of Health will be used to support the operation of overdose prevention centers.

Key Points: 
  • No funds from the National Institutes of Health will be used to support the operation of overdose prevention centers.
  • Grantees at NYU and Brown will study the impact of sites already in operation to elucidate the study aims.
  • "Overdose prevention centers have saved lives over the past year," said NYC Health Commissioner Ashwin Vasan, MD, PhD.
  • We look forward to partnering with NYU Langone, OnPoint, and the State of Rhode Island on a robust, long-term study.

Greenhouse Treatment Center to Host Fentanyl Documentary Screening and Community Panel Discussion on May 10

Retrieved on: 
Friday, May 5, 2023
Greenhouse, Naloxone, Heroin, Thought, Death, J. Erik Jonsson Central Library, Drug, Patient, Risk, Fentanyl

Also in 2021, 588 pounds of fentanyl was seized: if two milligrams of fentanyl is a lethal amount, 588 pounds of fentanyl could wipe out nearly 40% of the entire country.

Key Points: 
  • Also in 2021, 588 pounds of fentanyl was seized: if two milligrams of fentanyl is a lethal amount, 588 pounds of fentanyl could wipe out nearly 40% of the entire country.
  • “For example, the fentanyl analogs that we’re seeing now in patients are far more deadly than the fentanyl of a year ago.
  • “Our goal with this event is to provide a real-time picture of the extent of this problem,” said Harrell.
  • “Fentanyl is continuing to evolve and we hope to provide the community with an accurate depiction of exactly what is being seen in our backyards.”

INDIANA HEALTH CENTERS EXPANDING ACCESS TO NALOXONE (NARCAN) AT 17 LOCATIONS

Retrieved on: 
Wednesday, May 3, 2023
Social services, Harm reduction, Emergency, Education, WIC, Mental health, Heroin, IHC, Death, Drug, Map, Administrative divisions of New York (state), Medical device, Pharmaceutical industry, Naloxone

Indianapolis, IN, USA – Indiana Health Centers, Inc. (IHC) will be installing NaloxBoxes at all their health centers and WIC locations across the state, making the life-saving medication Naloxone available to anyone who needs it.

Key Points: 
  • Indianapolis, IN, USA – Indiana Health Centers, Inc. (IHC) will be installing NaloxBoxes at all their health centers and WIC locations across the state, making the life-saving medication Naloxone available to anyone who needs it.
  • Anyone who wants to obtain a free Naloxone kit can do so anytime, without an appointment or identifying themselves.
  • “IHC embraces harm reduction aligned with Indiana Governor Holcomb’s initiative to have broader access to Naloxone in each county.
  • Once supplies are stocked and the boxes are installed and functional, the IHC locations offering these NaloxBoxes will be listed on Overdose Lifeline’s Indiana Naloxone boxes and distribution center map.

Operation UNITE and HarborPath Awarded $1 Million Grant to Fund Naloxone-Plus Program in Kentucky

Retrieved on: 
Thursday, April 27, 2023
FDA, Health, Law Enforcement, Emergency Services, Other Health, Public Policy, Government, Pharmaceutical, Other Philanthropy, Philanthropy, Mental Health, Managed Care, General Health, Fund Raising, Foundation, State, Local, FFF, Partnership, Education, Friends, Hope, Multimedia, Drug overdose, Heroin, Organization, School, Funeral, Risk, Drug, UNITE, Commonwealth, Fentanyl, Library, Treatment, Appalachia, Mobile phone, Pharmaceutical industry, Management, Naloxone

Operation UNITE received a $1 million grant from the Kentucky Opioid Abatement Advisory Commission on Thursday to launch its Naloxone-Plus initiative in partnership with HarborPath.

Key Points: 
  • Operation UNITE received a $1 million grant from the Kentucky Opioid Abatement Advisory Commission on Thursday to launch its Naloxone-Plus initiative in partnership with HarborPath.
  • View the full release here: https://www.businesswire.com/news/home/20230427005905/en/
    Kentucky Attorney General Daniel Cameron announced that Operation UNITE has received a $1 million grant to launch its Naloxone-Plus initiative across 33 counties in eastern Kentucky.
  • UNITE offers the availability, distribution, and education of naloxone, coupled with prevention efforts, within its 33-county service region in eastern Kentucky.
  • “We are honored to partner with Operation UNITE in launching the Naloxone-Plus program and providing access to naloxone in the Appalachian Region.

National Institutes of Health Awards Grant for Pivotal Clinical Trial of gammaCore™ (nVNS) in Patients with Opioid Use Disorders

Retrieved on: 
Wednesday, April 26, 2023
Linda, Emory University, Oxycodone, Life, Opioid, Clinical trial, Radiology, Opioid use disorder, Journal of Bioscience and Bioengineering, Woman, Georgia Institute of Technology College of Computing, OUD, Nerve conduction study, Research, Heroin, Bangladesh Technical Education Board, Pain, ECOR, Professor, Kanimozhi NVN Somu, Death, MD, Patient, Risk, Computer engineering, ElectroCore, NIDA, Psychiatry, National Institute on Drug Abuse, Biological engineering, United, HEAL, Fentanyl, Family, NIH, Electricity, Pharmaceutical industry

Opioid use disorder represents a national crisis with devastating consequences.

Key Points: 
  • Opioid use disorder represents a national crisis with devastating consequences.
  • The primary efficacy endpoint of this study will be peak difference in the Subjective Opioid Withdrawal Score (SOWS) between nVNS and sham treatment on day 2 and 3 of the initial withdrawal period.
  • Dr. Douglas Bremner, Professor of Psychiatry and Radiology at Emory University School of Medicine and a principal investigator for the study commented, “We are pleased to be able to proceed with a pivotal trial to define the role of nVNS as a potential treatment for opioid use disorder.
  • “The personal, family and financial costs of opioid addiction represent an ongoing crisis in America and nVNS could offer a safe, effective and novel way to help patients through the critical initial phase of withdrawal thereby saving them pain and distress while also saving the healthcare system significant expense.”

BayMark Opens New Treatment Centers for Opioid Use Disorder

Retrieved on: 
Wednesday, April 26, 2023
Residential treatment center, Opioid, Buprenorphine, Senior counsel, OH, COVID-19, Opioid use disorder, Fentanyl, Drug overdose, Heroin, OTP, MAT, Drug, Patient, Fortification, Methadone, Pharmaceutical industry

BENBROOK, Texas and PARMA HEIGHTS, Ohio, April 25, 2023 /PRNewswire-PRWeb/ -- The need for access to treatment for opioid use and other substance use disorders has unfortunately only grown in urgency over the last few years as the opioid epidemic was not only eclipsed but exacerbated by the COVID-19 pandemic. BayMark Health Services has continued to expand services in response to this overwhelming need with the recent expansion of our MedMark Treatment Centers program locations for opioid use disorder in Texas and Ohio.

Key Points: 
  • BayMark Health Services has continued to expand services in response to this overwhelming need with the recent expansion of our MedMark Treatment Centers program locations for opioid use disorder in Texas and Ohio.
  • This week BayMark announced that its Fort Worth Opioid Treatment Program (OTP) has expanded into Benbrook, TX.
  • Located at 6240 Southwest Blvd, the location provides treatment with methadone or buprenorphine medications, laboratory services and health screenings.
  • MedMark Treatment Centers are known across the country as providers of comprehensive, individualized programs for adults struggling with opioid addiction.

Experts to Discuss the Collateral Impact of Opioid Misuse in Upcoming Webinar

Retrieved on: 
Tuesday, April 25, 2023
National Institute on Drug Abuse, Drug, Communication, Advertising, Drug Enforcement Administration, Partnership, New Jersey Division of Alcoholic Beverage Control, New Jersey Division of Consumer Affairs, Addiction, Culture, Human services, United States Department of Health and Human Services, COVID-19, Consumer protection, New Jersey Department of Health, Heller School for Social Policy and Management, Infection, Outreach, Heroin, Government, Assistant, Organization, Social policy, Capacity, MD, Division, New Jersey Medical School, Prohibition, Domestic violence, New Jersey State Police, Health, Fentanyl, A True Tale of Robin Hood, Pharmaceutical industry

The webinar, “The Collateral Impact of Opioid Misuse,” will be held at 11 a.m. Thursday, April 27, and will examine the indirect yet significant effects of opioid misuse and addiction.

Key Points: 
  • The webinar, “The Collateral Impact of Opioid Misuse,” will be held at 11 a.m. Thursday, April 27, and will examine the indirect yet significant effects of opioid misuse and addiction.
  • “Opioid use, misuse and addiction can manifest itself in ways beyond the health and wellbeing of the person using substances,” said PDFNJ Executive Director Angelo Valente.
  • “This webinar will provide vital information on the downstream impact of opioid misuse and addiction and what can be done to prevent it.”
    The webinar will be the fourth in the 2023 Knock Out Opioid Abuse Day Learning Series.
  • To learn more about the Knock Out Opioid Abuse Day and for a schedule of webinars, please visit knockoutday.drugfreenj.org .

‘Tranq,’ or Xylazine Can Worsen the Overdose Crisis Warns Laguna Treatment Hospital

Retrieved on: 
Wednesday, April 12, 2023
Amputation, Xylazine, Methamphetamine, Naloxone, Abscess, Laguna, Heroin, Cocaine, Hypoventilation, Death, Mental health, Fentanyl, Pharmaceutical industry, Drug

Illicit xylazine use was reported back in the early 2000s and became a worrying issue in Puerto Rico in the mid-2000s.

Key Points: 
  • Illicit xylazine use was reported back in the early 2000s and became a worrying issue in Puerto Rico in the mid-2000s.
  • It wasn’t until 2019 that its presence was felt nationwide when it was primarily used as a fentanyl additive.
  • “Xylazine really has the potential to make this overdose crisis the country’s experiencing significantly worse, and unfortunately, I think that’s what might happen,” said Dr. Gary Mitrevolis, medical director at Laguna Treatment Hospital.
  • Xylazine is a nonopioid anesthetic commonly found alongside fentanyl; even if a fentanyl overdose were identified and naloxone administered, there is no antidote for the respiratory depression induced by xylazine.

Prophetic Book Makes History in the Heavens, Christened by Campus Students Preceding Asbury Revival and Jesus Revolution Movie

Retrieved on: 
Friday, March 31, 2023
Destiny, Darkness, Assembly of the International Space Station, The Christian Post, Brainsway, Jesus Revolution, Generation Z, Depression, University, Lord, Methamphetamine, Benzodiazepine, Ebook, Weeping Angel, International Space Station, Anxiety, Secret Code, Lionsgate, Generation, United States drug overdose death rates and totals over time, Hope, Glenville State University, Research, Sacredness, Millennials, History, Rotten Tomatoes, Heroin, Cedarville University, Samford University, Student, Dream, Cocaine, COVID-19, University of Kentucky, Love, Immanuel College, Asbury, Adolescence, Washington and Lee University, Letter, Death, Prophecy, Asbury University, Social media, ISS, JAMA, Video game, Nursing, Book, Amusement park

Before that unprecedented event, the book Prophetic Matrix: Unlock The Secret Code To Your Destiny debuted at Immanuel College in Australia.

Key Points: 
  • Before that unprecedented event, the book Prophetic Matrix: Unlock The Secret Code To Your Destiny debuted at Immanuel College in Australia.
  • And now the movie Jesus Revolution, which was released the day following the last day of the Asbury revival, has amassed $42million in earnings domestically.
  • Rotten Tomatoes , the review aggregator site, listed a 99% approval rating among the general audience for Jesus Revolution.
  • It is not a coincidence that a campus revival broke out at Asbury University, with thousands of people attending from around the world.